Author/Authors :
Al-Asfar, Said M. North West Armed Forces Hospital - Department of Internal Medicine, Division of Rheumatology, Saudi Arabia , Attar, Mohammad Al-Hada Armed Forces Hospital - Department of Internal Medicine, Saudi Arabia , Shacfeh, Hasan Al-Hada Armed Forces Hospital - Department of Medicine and Rehabilitation, Saudi Arabia
Abstract :
Undifferentiated spondyloarthropathies (USPA) can sometimes be refractory to usual disease modifying agents. Anti-tumor necrosis factor (TNF)-alpha agents have been shown to be effective in spondyloarthropathies. Few articles described the efficacy of TNF-alpha antagonists in USPA. Our patient had refractory Achilles tendonitis as an early manifestation of USPA which responded dramatically to infliximab treatment.
